Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alfresa Holdings ( (JP:2784) ) has issued an announcement.
Alfresa Holdings has announced its 25–27 Mid-term Management Plan, part of its Vision 2032 Stage 2, which focuses on strengthening core businesses and expanding its supply chain services. The plan includes strategic investments in growth and new businesses, rigorous cost control, and sustainability management to enhance corporate value and ensure a stable supply chain.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2120.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare industry, focusing on pharmaceuticals and healthcare-related services. The company aims to extend healthy life expectancies and contribute to community healthcare through innovative business strategies and a comprehensive supply chain service model.
Average Trading Volume: 511,221
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen414.9B
Learn more about 2784 stock on TipRanks’ Stock Analysis page.